Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Mar 7;88(10):1004-1006.
doi: 10.1212/WNL.0000000000003694. Epub 2017 Feb 8.

Tumefactive Demyelination Following Treatment for Relapsing Multiple Sclerosis With Alemtuzumab

Affiliations
Case Reports

Tumefactive Demyelination Following Treatment for Relapsing Multiple Sclerosis With Alemtuzumab

Joshua Barton et al. Neurology. .

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback